Etiqueta: clinical trial
-
US FDA Green Lights Second Duchenne’s Muscular Dystrophy Patient To Receive Human Umbilical Cord Stem Cells In US
(PRWEB) MAY 26, 2016 After several promising treatments in Panama using stem cell technology developed by Medistem Panama Inc. at the City of Knowledge in Panama, a 6 year-old Duchenne’s muscular dystrophy patient received his first umbilical cord tissue-derived mesenchymal stem cells in the US earlier this year following FDA approval of a second application…
-
Duchenne’s Patient Ryan Benton Discusses His Experience with Stem Cell Therapy
Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne’s muscular dystrophy. The US FDA granted Ryan this trial under compassionate use. Ryan first began treatments at the Stem Cell Institute in Panama before being able to receive treatments in his hometown of Wichita,…
-
PRECISE: Adipose-derived stem cells show utility as therapy
Cardiology Today PRECISE is The Randomized Clinical Trial of Adipose-Derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium, a double blind, placebo-controlled trial involving 27 patients with chronic ischemic heart disease with HF, angina or both, who were not eligible for percutaneous or surgical revascularization. The patients in the study underwent a liposuction to…
-
Arteriocyte gets FDA approval to begin critical limb ischemia clinical trial
Medcity News Critical limb ischemia is an advanced form of peripheral artery disease that causes hundreds of thousands of amputations per year. This condition is attractive to stem cell intervention because even a marginal improvement in circulation may be enough to prevent amputation. Previous work from Japan and Mike Murphy’s group at Indiana has demonstrated…
-
Study Shows Patient’s Own Stem Cells Help Stroke Recovery: 16 Treated Patients Improve in Comparison to 36 Controls
Lee et al Stem Cells 28:1099 Stroke is caused by blocked circulation to parts of the brain usually as a result of a blood clot. Outcomes of stroke are generally proportional to the length of time the circulation was blocked and to the amount of brain tissue injury and death. Although the introduction of “clot…